Departement of Obstet/Gynecol, Lund University Hospital, Lund, Sweden.
Anticancer Res. 2010 Sep;30(9):3727-30.
Uterine clear cell carcinoma (UCC) and uterine papillary serous carcinoma (UPSC) are rare entities that differ in clinical behavior from endometrial adenocarcinoma. Compared with endometrioid adenocarcinoma, they more often metastasize early and more commonly in the upper abdomen including the omentum. Treatment programs of UCC and UPSC at different stages vary and range from no adjuvant therapy in stage Ia to a wide variety of chemotherapies and radiotherapies in more advanced stages. This study presents the outcome of 109 patients with UCC or UPSC treated according to essentially the same treatment program from May 1993 to December 2004. Most patients were treated with a simple hysterectomy with no further adjuvant treatment. In stage Ia, 2/46 patients died of their disease and amongst all the stages, 30/109 patients died of their disease. These survival outcomes are comparable to or better than those presented previously.
子宫透明细胞癌(UCC)和子宫乳头状浆液性腺癌(UPSC)是罕见的实体肿瘤,其临床行为与子宫内膜腺癌不同。与子宫内膜样腺癌相比,它们更常早期转移,更常见于上腹部,包括网膜。UCC 和 UPSC 在不同阶段的治疗方案不同,从 I 期 a 期的无辅助治疗到更晚期的各种化疗和放疗。本研究报告了 1993 年 5 月至 2004 年 12 月期间根据基本相同的治疗方案治疗的 109 例 UCC 或 UPSC 患者的结果。大多数患者接受单纯子宫切除术,无需进一步辅助治疗。在 I 期 a 期,46 例患者中有 2 例死于疾病,所有分期中,109 例患者中有 30 例死于疾病。这些生存结果与之前报道的相似或更好。